Dovitinib
编号: 16071106
Cas号: 405169-16-6
纯度: 98% by HPLC
Dovitinib, also known as TKI-258 or CHIR-258, is an orally bioavailable FGFR3 inhibitor, which strongly binds to fibroblast growth factor receptor 3 (FGFR3) and inhibits its phosphorylation, which may result in the inhibition of tumor cell proliferation and the induction of tumor cell death. In addition, this agent may inhibit other members of the RTK superfamily, including the vascular endothelial growth factor receptor; fibroblast growth factor receptor 1; platelet-derived growth factor receptor type 3; FMS-like tyrosine kinase 3; stem cell factor receptor (c-KIT); and colony-stimulating factor receptor 1; this may result in an additional reduction in cellular proliferation and angiogenesis, and the induction of tumor cell apoptosis.
仅供研究使用。 我们不向患者出售。
化学信息
| 名称 | Dovitinib |
|---|---|
| Iupac 化学名称 | 4-Amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone 2-hydroxypropanoate |
| 同义词 | TKI258; TKI-258 |
| 英文同义词 | TKI258; TKI-258 |
| 分子式 | C24H27FN6O4 |
| 分子量 | 482.51 |
| Smile | OC(C(=O)O)C.NC1=C(C(NC2=CC=CC(=C12)F)=O)C1=NC2=C(N1)C=C(C=C2)N2CCN(CC2)C |
| InChiKey | ZRHDKBOBHHFLBW-UHFFFAOYSA-N |
| InChi | InChI=1S/C21H21FN6O.C3H6O3/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29;1-2(4)3(5)6/h2-6,11H,7-10H2,1H3,(H,24,25)(H3,23,26,29);2,4H,1H3,(H,5,6) |
| Cas号 | 405169-16-6 |
| 相关CAS号 |
订购信息
| 包装 | 价格 | 库存 | 纯度 | 备货期 |
|---|---|---|---|---|
| 大货 | 询价 | 询价 | 询价 |
